Meningioma Study: Genes, Health & Life
Part of Brain & nervous system, Cancer clinical trials.
This study looks at how your tumor's genes, personal health habits, and other factors affect your long-term health after a meningioma diagnosis. You'll be asked to complete surveys about your health and experiences—no new treatments or procedures are involved.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You can speak and read English
- You have been diagnosed with a meningioma (a type of brain tumor)
- You do not have serious mental health problems that would interfere with taking surveys
- You can understand the study and give your permission to take part
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to validate a French questionnaire about quality of life for people with meningiomas. By answering some questionnaires, you can help doctors better understand how this condition affects daily life.
This study measures how thinking and memory change after surgery to remove a meningioma near the front or side of the brain. It may help doctors better understand what to expect and how cognitive recovery can differ from person to person.
This study tests a French version of a questionnaire that measures quality of life in people with meningioma. Participation involves filling out the questionnaire to help doctors better understand how the tumor affects your daily life.
This study is looking at tiny particles called extracellular vesicles in the blood of people with meningioma, a type of brain tumor. The goal is to learn more about these particles and how they relate to the tumor, which may help in understanding the disease better.
This study follows people with lower-grade (WHO grade 2 or less) brain tumors using repeat MRI scans over time. It helps doctors understand how these tumors change and which patients may safely delay treatment at first.
This study looks at people who had surgery for more aggressive meningiomas (grade 2 or 3) and tries to learn what factors relate to survival. The results may help doctors better predict outcomes for future patients.
Hear when a new Meningioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.